↓ Skip to main content

Dove Medical Press

Article Metrics

Active axial spondyloarthritis: potential role of certolizumab pegol

Overview of attention for article published in Therapeutics and Clinical Risk Management, February 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 tweeters

Readers on

mendeley
18 Mendeley
Title
Active axial spondyloarthritis: potential role of certolizumab pegol
Published in
Therapeutics and Clinical Risk Management, February 2014
DOI 10.2147/tcrm.s53675
Authors

Sriya Ranatunga, Anne Miller

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 6%
Unknown 17 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 28%
Student > Master 4 22%
Student > Bachelor 2 11%
Student > Postgraduate 2 11%
Student > Ph. D. Student 1 6%
Other 2 11%
Unknown 2 11%
Readers by discipline Count As %
Medicine and Dentistry 10 56%
Social Sciences 2 11%
Economics, Econometrics and Finance 1 6%
Computer Science 1 6%
Agricultural and Biological Sciences 1 6%
Other 1 6%
Unknown 2 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 February 2014.
All research outputs
#2,117,528
of 4,505,915 outputs
Outputs from Therapeutics and Clinical Risk Management
#218
of 397 outputs
Outputs of similar age
#55,149
of 127,495 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#22
of 32 outputs
Altmetric has tracked 4,505,915 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 397 research outputs from this source. They receive a mean Attention Score of 2.8. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 127,495 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.